Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
15.76
-0.02 (-0.13%)
Nov 20, 2026, 12:04 PM EST - Market open
Arcus Biosciences Market Cap
Arcus Biosciences has a market cap or net worth of $2.27 billion as of November 20, 2026. It is the 5,780th most valuable company in the world and the 1,624th biggest in the United States. Its market cap has increased by 3.94% in one year.
Market Cap
2.27B
Enterprise Value
1.82B
1-Year Change
3.94%
Global Rank
Country Rank
#1,624 United States
Category
ChartMarket Cap Chart
Since March 15, 2018, Arcus Biosciences's market cap has increased from $708.10M to $2.27B, an increase of 220.48%. That is a compound annual growth rate of 14.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 2.27B | -11.80% |
| Dec 31, 2025 | 2.57B | 88.83% |
| Dec 31, 2024 | 1.36B | -4.69% |
| Dec 29, 2023 | 1.43B | -4.52% |
| Dec 30, 2022 | 1.50B | -47.33% |
| Dec 31, 2021 | 2.84B | 68.68% |
| Dec 31, 2020 | 1.69B | 263.86% |
| Dec 31, 2019 | 463.20M | -3.26% |
| Dec 31, 2018 | 478.80M | -32.38% |
| Mar 15, 2018 (IPO) | 708.10M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xencor | 2.55B |
| IDEAYA Biosciences | 2.53B |
| Zai Lab | 2.46B |
| NewAmsterdam Pharma Company | 2.34B |
| Pharvaris | 2.24B |
| Celldex Therapeutics | 2.20B |
| Lakefront Biotherapeutics NV | 2.17B |
| Palvella Therapeutics | 2.13B |